{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:33:10Z","timestamp":1775057590360,"version":"3.50.1"},"reference-count":78,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T00:00:00Z","timestamp":1347840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30930100"],"award-info":[{"award-number":["30930100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81072218"],"award-info":[{"award-number":["81072218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30872872"],"award-info":[{"award-number":["30872872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81102060"],"award-info":[{"award-number":["81102060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talented Professionals of Sichuan Province in China","award":["09ZQ026-037"],"award-info":[{"award-number":["09ZQ026-037"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Pathology Medicine"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Thalidomide was originally marked as a sedative and anti\u2010emetic, but was withdrawn after severe teratogenic effects had been discovered. More recently it has been claimed to alleviate a wide range of inflammatory disorders and malignancies. Studies showed that thalidomide might play a role in the management of some oral premalignant conditions and its potential to be an adjunct in the prevention of oral cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of this study is to summarize the characteristics and feasibility of thalidomide in the development and prevention of oral precancerosis, and to draw attentions of researchers to its therapeutic potential in oral cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Databases were searched on the basis of<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>ub<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>ed and<jats:styled-content style=\"fixed-case\">EM<\/jats:styled-content>base. Thalidomide associated with the oral lichen planus, chronic discoid lupus erythematosus (<jats:styled-content style=\"fixed-case\">CDLE<\/jats:styled-content>) and oral cancer were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We have summed up the structure and pharmacokinetics of thalidomide, possible role of thalidomide in cancer prevention, as well as the recent data concerning its effects in prevention of oral premalignant conditions and potential for the treatment of oral cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Therapeutic effects of thalidomide in oral lichen planus and<jats:styled-content style=\"fixed-case\">CDLE<\/jats:styled-content>have been discussed by clinical trials. And increasing evidences from<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>experiments show that thalidomide is a promising anticancerous agent for oral cancer, which should be paid attention to. It is necessary to perform more studies and clinical trials of large sample size to clarify underlying mechanisms and demonstrate the potential roles of thalidomide in clinical routine management of oral diseases.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jop.12004","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T05:16:19Z","timestamp":1347858979000},"page":"355-362","source":"Crossref","is-referenced-by-count":10,"title":["Thalidomide: features and potential significance in oral precancerous conditions and oral cancer"],"prefix":"10.1111","volume":"42","author":[{"given":"Xin","family":"Jin","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Xing","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Mu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjing","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(00)00008-5"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.4.195"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.4065\/82.7.878"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196212062672305"},{"key":"e_1_2_8_7_1","first-page":"65","article-title":"Thalidomide revisited","volume":"13","author":"D'Arcy PF","year":"1994","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90122-X"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03307-0"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.7.827"},{"key":"e_1_2_8_11_1","first-page":"201","article-title":"Selecting topical and systemic agents for recurrent aphthous stomatitis","volume":"68","author":"Eisen D","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70276-3"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200102000-00016"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03211.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2593"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1960.tb01217.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199207020-00004"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80085-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530070109"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600810719"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357001774660"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1998)10:3<223::AID-CHIR4>3.0.CO;2-A"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127009903901108"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122012698"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/340133"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010555"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1965.tb02054.x"},{"issue":"6","key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/clinchem\/43.6.1094","article-title":"Handling of blood samples for determination of thalidomide","volume":"43","author":"Eriksson T","year":"1997","journal-title":"Clin Chem"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0090-9556(25)07646-9","article-title":"Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers","volume":"17","author":"Chen TL","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601579"},{"issue":"12","key":"e_1_2_8_31_1","first-page":"9","article-title":"Research on thalidomide in solid tumors, hematologic malignancies, and supportive care","volume":"14","author":"Hussein MA","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.11.008"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-341669"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.606943"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.03.027"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.14.2710"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-006"},{"key":"e_1_2_8_38_1","first-page":"41","article-title":"Interferon\u2010alpha plus capecitabine and thalidomide in patients with metastatic renal cell cancer","volume":"7","author":"Amato RJ","year":"2008","journal-title":"J Exp Ther Oncol"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23164"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.699"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.07.023"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100938200"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.6.2644"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207230"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.3.L600"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.4082"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004170050106"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0498-408"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1323"},{"key":"e_1_2_8_50_1","first-page":"3349","article-title":"Thalidomide and its analogues inhibit lipopolysaccharide\u2010mediated Iinduction of cyclooxygenase\u20102","volume":"7","author":"Fujita J","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.12.1487"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.11.1885"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.210"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4525"},{"key":"e_1_2_8_55_1","first-page":"593","article-title":"A novel subclass of thalidomide analogue with anti\u2010solid tumor activity in which caspase\u2010dependent apoptosis is associated with altered expression of bcl\u20102 family proteins","volume":"63","author":"Marriott JB","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0528.1987.tb00480.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2011.04.009"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.2334\/josnusd.49.89"},{"key":"e_1_2_8_59_1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/00015550510036676","article-title":"Premalignant nature of oral lichen planus","volume":"85","author":"Laeijendecker R","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2010.02.016"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(98)00116-X"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.09.006"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.01.009"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2010.03.034"},{"key":"e_1_2_8_65_1","first-page":"1109","article-title":"Treatment of erosive oral lichen planus with thalidomide","volume":"130","author":"Macario\u2010Barrel A","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890350136031"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.12.1442"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.84078"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00953.x"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1983.tb04600.x"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.149"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0151-9638(05)79503-X"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23734"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.5482\/ha-1163"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg083"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.06.009"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2008.00737.x"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(00)00701-1"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22867"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjop.12004","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjop.12004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jop.12004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:41:26Z","timestamp":1744152086000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jop.12004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,17]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/jop.12004"],"URL":"https:\/\/doi.org\/10.1111\/jop.12004","archive":["Portico"],"relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,17]]}}}